Softhale NV

📍 Diepenbeek, Belgium🗓 Founded 2016👥 16 employees💰 Last funded Sep 2019
Based in Diepenbeek, Belgium, Softhale N.V. is a pharmaceutical company specializing in the development of inhalable respiratory products for the medical treatment of various indications including, for example, Asthma or COPD. In Softhale’s office and labs, the focus lies on product development, formulation development, and analytical capabilities. The team is led by international industry experts (hardware, formulation, analytics, manufacturing, commercialization) and supported by external (inter-)national services providers. The Company’s proprietary, propellant-free, purely mechanical device delivers medication to the lungs more effectively than other types of inhalers and is poised to change the treatment paradigm in large markets including asthma and COPD. Softhale’s products to be used for pharmaceutical development and approval processes are innovative as well as cost-optimized. Softhale is ISO 13485: 2016 certified.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
Switzerland
2
Frequently asked questions
Who invested in Softhale NV?
Softhale NV has 2 investors on record on gritt.io, 2 mid-stage.
When did Softhale NV last raise funding?
The most recent investment in Softhale NV recorded on gritt.io was in September 2019.
When was Softhale NV founded?
Softhale NV was founded in 2016.
What industry is Softhale NV in?
Softhale NV operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Softhale NV based?
Softhale NV is headquartered in Diepenbeek, Belgium.